<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Hansa Biopharma - Directed Share Issue of SEK 372 million]]></title><description><![CDATA[<p dir="auto">Hansa Biopharma AB: Hansa Biopharma Announces Successful Execution of a Directed Share Issue of SEK 372 million (~USD 34.6 million)</p>
<p dir="auto"><a href="https://www.hansabiopharma.com/media/press-releases/2024/hansa-biopharma-announces-successful-execution-of-a-directed-share-issue-of-sek-372-million-usd-34-6-million/" rel="nofollow ugc">https://www.hansabiopharma.com/media/press-releases/2024/hansa-biopharma-announces-successful-execution-of-a-directed-share-issue-of-sek-372-million-usd-34-6-million/</a><br />
...</p>
<p dir="auto">"Priset för de Nya Aktierna är 29,12 SEK per Ny Aktie, motsvarande stängningspriset av Hansas aktier på Nasdaq Stockholm den 11 april 2024."</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/446351/hansa-biopharma-directed-share-issue-of-sek-372-million</link><generator>RSS for Node</generator><lastBuildDate>Fri, 19 Jun 2026 12:02:42 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/446351.rss" rel="self" type="application/rss+xml"/><pubDate>Fri, 12 Apr 2024 04:12:29 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Hansa Biopharma - Directed Share Issue of SEK 372 million on Fri, 12 Apr 2024 04:36:21 GMT]]></title><description><![CDATA[<p dir="auto">Super-super nyhed - så er finansieringen på den mellemlange bane på plads. Frygtede lidt at vi skulle ud i en kæmpe udvanding à la Xbrane. Spændende at se om shorterne holder fast i deres positioner eller vælger et exit nu da finansieringen er på plads.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9488245</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9488245</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Fri, 12 Apr 2024 04:36:21 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma - Directed Share Issue of SEK 372 million on Fri, 12 Apr 2024 04:27:28 GMT]]></title><description><![CDATA[<p dir="auto">Hansa Biopharma stärker kassan genom riktad nyemission på 372 miljoner kronor (Finwire)</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">



<a href="https://www.placera.se/telegram/hansa-biopharma-starker-kassan-genom-riktad-nyemission-pa-372-miljoner-kronor-2024-04-12" title="Hansa Biopharma stärker kassan genom riktad nyemission på 372 miljoner kronor - Placera.se">
<img src="https://www.placera.se/static/images/default-image.png" class="card-img-top not-responsive" style="max-height: 15rem;" alt="Link Preview Image" onerror="this.parentElement.remove()" />
</a>



<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.placera.se/telegram/hansa-biopharma-starker-kassan-genom-riktad-nyemission-pa-372-miljoner-kronor-2024-04-12">
Hansa Biopharma stärker kassan genom riktad nyemission på 372 miljoner kronor - Placera.se
</a>
</h5>
<p class="card-text line-clamp-3">Hansa Biopharma stärker kassan genom riktad nyemission på 372 miljoner kronor</p>
</div>
<a href="https://www.placera.se/telegram/hansa-biopharma-starker-kassan-genom-riktad-nyemission-pa-372-miljoner-kronor-2024-04-12" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://www.placera.se/static/icons/favicon-placera.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0">placera.se <span class="text-secondary">(www.placera.se)</span></p>
</a>
</div></p>
<p dir="auto">&quot;Bland investerarna som tecknat aktier finns Braidwell, Redmile Group, Fjärde AP-fonden, Sphera Healthcare, Woodline Partners, en entitet som förvaltas av Heights Capital Ireland och Maven Investment Partners.&quot;</p>
<p dir="auto">...</p>
<p dir="auto">Hansa Biopharma har framgångsrikt genomfört en riktad nyemission om 372 MSEK (~ 34,6 MUSD)</p>
<p dir="auto"><a href="https://mb.cision.com/Main/1219/3960623/2727973.pdf" rel="nofollow ugc">https://mb.cision.com/Main/1219/3960623/2727973.pdf</a><br />
(Cision)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9488255</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9488255</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Fri, 12 Apr 2024 04:27:28 GMT</pubDate></item></channel></rss>